Seyed Mohsen Razavi

633 total citations
36 papers, 522 citations indexed

About

Seyed Mohsen Razavi is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Seyed Mohsen Razavi has authored 36 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Seyed Mohsen Razavi's work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Seyed Mohsen Razavi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Seyed Mohsen Razavi collaborates with scholars based in Iran and Sweden. Seyed Mohsen Razavi's co-authors include Mahmood Jeddi‐Tehrani, Ramazan Ali Sharifian, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi, Ali Memarian, Hossein Asgarian‐Omran, Hodjatallah Rabbani, Fazel Shokri, Alipasha Meysamie and Fazel Shokri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Seyed Mohsen Razavi

33 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seyed Mohsen Razavi Iran 14 262 194 130 104 94 36 522
Paul Milne United Kingdom 13 422 1.6× 49 0.3× 136 1.0× 85 0.8× 159 1.7× 41 801
Magan Trottier United States 10 92 0.4× 74 0.4× 193 1.5× 151 1.5× 125 1.3× 17 572
Candis Morrison United States 10 134 0.5× 316 1.6× 45 0.3× 308 3.0× 118 1.3× 27 679
Henk Wind Netherlands 7 191 0.7× 132 0.7× 186 1.4× 105 1.0× 109 1.2× 11 561
Jennifer Thompson United States 11 126 0.5× 68 0.4× 124 1.0× 111 1.1× 147 1.6× 19 569
Guillem Clot Spain 12 105 0.4× 190 1.0× 189 1.5× 234 2.3× 140 1.5× 23 491
Musa Alharbi Saudi Arabia 9 185 0.7× 98 0.5× 79 0.6× 32 0.3× 69 0.7× 30 478
Daniel C. Moreira United States 11 184 0.7× 139 0.7× 247 1.9× 14 0.1× 187 2.0× 69 739
Melody Smith United States 15 549 2.1× 71 0.4× 269 2.1× 85 0.8× 487 5.2× 39 1.1k
Sara Wichner United States 6 208 0.8× 62 0.3× 369 2.8× 57 0.5× 201 2.1× 7 807

Countries citing papers authored by Seyed Mohsen Razavi

Since Specialization
Citations

This map shows the geographic impact of Seyed Mohsen Razavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seyed Mohsen Razavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seyed Mohsen Razavi more than expected).

Fields of papers citing papers by Seyed Mohsen Razavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seyed Mohsen Razavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seyed Mohsen Razavi. The network helps show where Seyed Mohsen Razavi may publish in the future.

Co-authorship network of co-authors of Seyed Mohsen Razavi

This figure shows the co-authorship network connecting the top 25 collaborators of Seyed Mohsen Razavi. A scholar is included among the top collaborators of Seyed Mohsen Razavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seyed Mohsen Razavi. Seyed Mohsen Razavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shabani, Ronak, Hamid Reza Asgari, Mahdi Karimi, et al.. (2022). In Vitro Elimination of EL4 Cancer Cells From Spermatogonia Stem Cells by Mirna-143- and 206-Loaded Folic Acid-Conjugated Plga Nanoparticles. Nanomedicine. 17(8). 531–545. 10 indexed citations
2.
Keramatipour, Mohammad, Mohammad Vaezi, Seyed Mohsen Razavi, et al.. (2022). Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model. Scientific Reports. 12(1). 12816–12816. 2 indexed citations
3.
Shabani, Ronak, Mohammad Najafi, Mahdi Karimi, et al.. (2021). The Role of MicroRNA 143 and MicroRNA 206 in The Regulation of Apoptosis in Mouse Lukemia Cancer Cells and Spermatogonial Cells.. SHILAP Revista de lepidopterología. 23(5). 544–551. 2 indexed citations
4.
Toogeh, Gholamreza, et al.. (2018). A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial.. PubMed. 12(2). 84–91. 15 indexed citations
5.
Zaker, Farhad, et al.. (2016). Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome.. PubMed. 5(2). 90–9. 5 indexed citations
6.
Mehrazma, Mitra, Elham Kalantari, Hamid Rezvani, et al.. (2015). Chromogenic In Situ Hybridisation Test for Breast Cancer Patients with Equivocal IHC Results - a Study from Iran. Asian Pacific Journal of Cancer Prevention. 16(17). 7695–7700.
7.
Hojjat‐Farsangi, Mohammad, Mahmood Jeddi‐Tehrani, Amir Hossein Daneshmanesh, et al.. (2015). Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia. PLoS ONE. 10(11). e0142310–e0142310. 13 indexed citations
8.
Ghalamfarsa, Ghasem, Farhad Jadidi‐Niaragh, Mohammad Mehdi Amiri, et al.. (2015). All-Trans-Retinoic Acid Differentially Regulates Proliferation of Normal and Leukemic B Cells From Different Subsets of Chronic Lymphocytic Leukemia. Nutrition and Cancer. 67(2). 285–291. 7 indexed citations
9.
Ghavamzadeh, Ardeshir, et al.. (2015). Medical oncology, history and its future in Iran.. PubMed. 18(11). 799–805. 3 indexed citations
10.
Jadidi‐Niaragh, Farhad, Mehdi Yousefi, Ali Memarian, et al.. (2013). Increased Frequency of CD8+and CD4+Regulatory T Cells in Chronic Lymphocytic Leukemia: Association with Disease Progression. Cancer Investigation. 31(2). 121–131. 43 indexed citations
11.
Ghalamfarsa, Ghasem, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi, et al.. (2013). Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia. Cytokine. 62(3). 439–445. 20 indexed citations
12.
Razavi, Seyed Mohsen, et al.. (2013). PREVALENCE OF MUSCULOSKELETAL DISORDERS AND IT'S RISK FACTORS AMONG, MOTHERS' HOME WORKING. 19(466). 390–394. 3 indexed citations
13.
Jadidi‐Niaragh, Farhad, Mahmood Jeddi‐Tehrani, Bita Ansaripour, et al.. (2012). Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia. Medical Oncology. 29(5). 3561–3569. 44 indexed citations
14.
Jadidi‐Niaragh, Farhad, Ghasem Ghalamfarsa, Ali Memarian, et al.. (2012). Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia. Tumor Biology. 34(2). 929–940. 61 indexed citations
15.
Shabani, Mahdi, Hossein Asgarian‐Omran, Mohammad Hojjat‐Farsangi, et al.. (2011). Comparative expression profile of orphan receptor tyrosine kinase ROR1 in Iranian patients with lymphoid and myeloid leukemias.. PubMed. 3(3). 119–25. 10 indexed citations
16.
Asgarian‐Omran, Hossein, Mohammad Hojjat‐Farsangi, Azam Roohi, et al.. (2010). Expression Profile of Galectin-1 and Galectin-3 Molecules in Different Subtypes of Chronic Lymphocytic Leukemia. Cancer Investigation. 28(7). 717–725. 21 indexed citations
17.
Hojjat‐Farsangi, Mohammad, Mahmood Jeddi‐Tehrani, Seyed Mohsen Razavi, et al.. (2009). Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia. Cancer Science. 100(12). 2346–2353. 27 indexed citations
18.
Hojjat‐Farsangi, Mohammad, Mahmood Jeddi‐Tehrani, Ali Akbar Amirzargar, et al.. (2008). Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia. Human Immunology. 69(10). 666–674. 11 indexed citations
19.
Jeddi‐Tehrani, Mahmood, Ramazan Ali Sharifian, Seyed Mohsen Razavi, et al.. (2006). Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 48(1). 109–116. 19 indexed citations
20.
Razavi, Seyed Mohsen, et al.. (2005). COMPARISON OF EROSION AND PERIODONTAL INDICES IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE. ACTA MEDICA IRANICA. 43(6). 422–424.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026